BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sood MM, Bota SE, McArthur E, Kapral MK, Tangri N, Knoll G, Zimmerman D, Garg AX. The three-year incidence of major hemorrhage among older adults initiating chronic dialysis. Can J Kidney Health Dis 2014;1:21. [PMID: 25780611 DOI: 10.1186/s40697-014-0021-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Jegatheswaran J, Hundemer GL, Massicotte-Azarniouch D, Sood MM. Anticoagulation in Patients With Advanced Chronic Kidney Disease: Walking the Fine Line Between Benefit and Harm. Can J Cardiol 2019;35:1241-55. [PMID: 31472820 DOI: 10.1016/j.cjca.2019.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Harel Z, Chertow GM, Shah PS, Harel S, Dorian P, Yan AT, Saposnik G, Sood MM, Molnar AO, Perl J, Wald RM, Silver S, Wald R. Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis. Canadian Journal of Cardiology 2017;33:737-46. [DOI: 10.1016/j.cjca.2017.02.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 8.6] [Reference Citation Analysis]
3 Liao J, Kuo L, Liu C, Chen S, Chao T. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with advanced chronic kidney and liver diseases. European Heart Journal Supplements 2022;24:A11-8. [DOI: 10.1093/eurheartj/suab154] [Reference Citation Analysis]
4 Bansal VK, Herzog CA, Sarnak MJ, Choi MJ, Mehta R, Jaar BG, Rocco MV, Kramer H. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report. American Journal of Kidney Diseases 2017;70:859-68. [DOI: 10.1053/j.ajkd.2017.08.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
5 Keskar V, McArthur E, Wald R, Harel Z, Zimmerman D, Molnar A, Garg AX, Lam N, McCallum MK, Bota SE, Perl J, Sood MM. The Authors Reply. Kidney Int 2017;92:767. [PMID: 28807268 DOI: 10.1016/j.kint.2017.06.006] [Reference Citation Analysis]
6 Molnar AO, van Walraven C, McArthur E, Fergusson D, Garg AX, Knoll G. Validation of administrative database codes for acute kidney injury in kidney transplant recipients. Can J Kidney Health Dis 2016;3:18. [PMID: 27057318 DOI: 10.1186/s40697-016-0108-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
7 Tanios BY, Itani HS, Zimmerman DL. Clopidogrel Use in End-Stage Kidney Disease. Semin Dial 2015;28:276-81. [DOI: 10.1111/sdi.12338] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
8 Roetker NS, Guo H, Ramey, Abd DR, Mcmullan CJ, Atkins GB, Wetmore JB. Hemodialysis Vascular Access and Risk of Major Bleeding, Thrombosis, and Cardiovascular Events: A Cohort Study. Kidney Medicine 2022. [DOI: 10.1016/j.xkme.2022.100456] [Reference Citation Analysis]
9 Tsai TJ, Chen WC, Huang YT, Yang YH, Feng IC, Wu WC, Hu HM, Wu DC, Hsu PI. Hemodialysis Increases the Risk of Lower Gastrointestinal Bleeding and Angiodysplasia Bleeding: A Nationwide Population Study. Gastroenterol Res Pract 2020;2020:7206171. [PMID: 32190042 DOI: 10.1155/2020/7206171] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mitic BP, Dimitrijevic ZM, Hosokawa K, Cvetkovic TP, Lazarevic MV, Tasic DD, Jovanovic A, Jancic N, Vrecic T, Ågren A, Wallen H. Platelet thrombus formation in patients with end-stage renal disease before and after hemodialysis as measured by the total thrombus-formation analysis system. Int Urol Nephrol. [DOI: 10.1007/s11255-022-03184-7] [Reference Citation Analysis]
11 Ashley J, Sood MM. Novel oral anticoagulants in chronic kidney disease: ready for prime time? Curr Opin Nephrol Hypertens 2018;27:201-8. [PMID: 29570468 DOI: 10.1097/MNH.0000000000000410] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
12 Keskar V, Sood MM. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con. Clin J Am Soc Nephrol 2016;11:2085-92. [PMID: 27797891 DOI: 10.2215/CJN.03200316] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
13 Wald R, Dorian P, Harel Z. Benefits and Risks of Anticoagulation in Dialysis Patients With Nonvalvular Atrial Fibrillation: Navigating Through Darkness. J Am Coll Cardiol 2020;75:286-8. [PMID: 31976866 DOI: 10.1016/j.jacc.2019.11.033] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Molnar AO, Sood MM. Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation. Semin Dial 2018;31:37-47. [PMID: 28699181 DOI: 10.1111/sdi.12637] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
15 Noel JA, Bota SE, Petrcich W, Garg AX, Carrero JJ, Harel Z, Tangri N, Clark EG, Komenda P, Sood MM. Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age. JAMA Intern Med 2019;179:1025-33. [PMID: 31180477 DOI: 10.1001/jamainternmed.2019.0631] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 25.5] [Reference Citation Analysis]
16 Molnar AO, Bota SE, Garg AX, Harel Z, Lam N, McArthur E, Nesrallah G, Perl J, Sood MM. The Risk of Major Hemorrhage with CKD. J Am Soc Nephrol 2016;27:2825-32. [PMID: 26823554 DOI: 10.1681/ASN.2015050535] [Cited by in Crossref: 57] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
17 Jayasurya R, Murugesan N, Kumar R, Dubey AK, Priyamvada PS, Swaminathan RP, Parameswaran S. Spontaneous nontraumatic subarachnoid hemorrhage without cerebrovascular malformations in a maintenance hemodialysis patient. Indian J Nephrol 2015;25:310-4. [PMID: 26628800 DOI: 10.4103/0971-4065.156909] [Reference Citation Analysis]
18 Molnar AO, van Walraven C, Fergusson D, Garg AX, Knoll G. Derivation of a Predictive Model for Graft Loss Following Acute Kidney Injury in Kidney Transplant Recipients. Can J Kidney Health Dis 2017;4:2054358116688228. [PMID: 28270930 DOI: 10.1177/2054358116688228] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
19 Randhawa MS, Vishwanath R, Rai MP, Wang L, Randhawa AK, Abela G, Dhar G. Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease: A Systematic Review and Meta-analysis. JAMA Netw Open 2020;3:e202175. [PMID: 32250434 DOI: 10.1001/jamanetworkopen.2020.2175] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
20 Stanifer JW, Pokorney SD, Chertow GM, Hohnloser SH, Wojdyla DM, Garonzik S, Byon W, Hijazi Z, Lopes RD, Alexander JH, Wallentin L, Granger CB. Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease. Circulation 2020;141:1384-92. [DOI: 10.1161/circulationaha.119.044059] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 12.5] [Reference Citation Analysis]